Adjuvant drugs in the treatment of on-off phenomena in Parkinson's disease.
D001549:Benzamides / Q000627:therapeutic use*; D001971:Bromocriptine / Q000627:therapeutic use*; D002262:Carboxy-Lyases / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage; D010300:Parkinson Disease / Q000175:diagnosis / Q000188:drug therapy*; D010627:Phenethylamines / Q000627:therapeutic use*; D012642:Selegiline / Q000627:therapeutic use*; D013976:Tiapamil Hydrochloride / Q000627:therapeutic use*
D001549:Benzamides; D010627:Phenethylamines; D012642:Selegiline; D001971:Bromocriptine; D007980:Levodopa; D002262:Carboxy-Lyases; D013976:Tiapamil Hydrochloride